Singedas, Newnamae .

HRN: 22-74-13  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/04/2025
CEFUROXIME 1.5GM (VIAL)
07/04/2025
07/04/2025
IVT
1.5g
Q8
S/P Exlap Salpingectomy Right
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines